Marie Couralet

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

EMBO molecular medicine

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Anthony Kypraios, Juba Bennour, Véronique Imbert, Léa David, Julien Calvo, Françoise Pflumio, Raphaël Bonnet, Marie Couralet, Virginie Magnone, Kevin Lebrigand, Pascal Barbry, Pierre S Rohrlich, Jean-François Peyron
Identifying Candidate Gene Drivers Associated with Relapse in Pediatric T-Cell Acute Lymphoblastic Leukemia Using a Gene Co-Expression Network Approach. Cancers 16 (9) (2024)
Anne Doye, Paul Chaintreuil, Chantal Lagresle-Peyrou, Ludovic Batistic, Valentine Marion, Patrick Munro, Celine Loubatier, Rayana Chirara, Nataël Sorel, Boris Bessot, Pauline Bronnec, Julie Contenti, Johan Courjon, Valerie Giordanengo, Arnaud Jacquel, Pascal Barbry, Marie Couralet, Nathalie Aladjidi, Alain Fischer, Marina Cavazzana, Coralie Mallebranche, Orane Visvikis, Sven Kracker, Despina Moshous, Els Verhoeyen, Laurent Boyer
RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activation. The Journal of experimental medicine 221 (10) (2024)
Anthony Kypraios, Juba Bennour, Véronique Imbert, Léa David, Julien Calvo, Françoise Pflumio, Raphaël Bonnet, Marie Couralet, Virginie Magnone, Kevin Lebrigand, Pascal Barbry, Pierre S Rohrlich, Jean-François Peyron
Identifying Candidate Gene Drivers Associated with Relapse in Pediatric T-Cell Acute Lymphoblastic Leukemia Using a Gene Co-Expression Network Approach. Cancers 16 (9) (2024)
Serena Diazzi, Alberto Baeri, Julien Fassy, Margaux Lecacheur, Oskar Marin-Bejar, Christophe A Girard, Lauren Lefevre, Caroline Lacoux, Marie Irondelle, Carine Mounier, Marin Truchi, Marie Couralet, Mickael Ohanna, Alexandrine Carminati, Ilona Berestjuk, Frederic Larbret, David Gilot, Georges Vassaux, Jean-Christophe Marine, Marcel Deckert, Bernard Mari, Sophie Tartare-Deckert
Blockade of the pro-fibrotic reaction mediated by the miR-143/-145 cluster enhances the responses to targeted therapy in melanoma. EMBO molecular medicine 14 (3) (2022)